Ambu A/S (OTCMKTS:AMBBY) Trading 3.4% Higher – Still a Buy?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBYGet Free Report)’s share price was up 3.4% during mid-day trading on Tuesday . The company traded as high as $13.78 and last traded at $13.78. Approximately 500 shares changed hands during trading, an increase of 495% from the average daily volume of 84 shares. The stock had previously closed at $13.33.

Ambu A/S Trading Up 3.4%

The firm’s 50-day simple moving average is $14.47 and its 200 day simple moving average is $14.94. The stock has a market cap of $3.24 billion, a P/E ratio of 40.53 and a beta of 0.93. The company has a current ratio of 2.72, a quick ratio of 1.63 and a debt-to-equity ratio of 0.08.

Ambu A/S (OTCMKTS:AMBBYGet Free Report) last released its quarterly earnings results on Wednesday, November 5th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a return on equity of 10.35% and a net margin of 10.00%.

Ambu A/S Company Profile

(Get Free Report)

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

See Also

Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.